Polar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspects by Magli, M. Cristina et al.
TECHNICAL NOTE Reproductive genetics
Polar body array CGH for prediction
of the status of the corresponding
oocyte. Part II: technical aspects
M. Cristina Magli1,*,†, Markus Montag2,†, Maria Ko ¨ster2, Luigi Muzi1,
Joep Geraedts3, John Collins4, Veerle Goossens5, Alan H. Handyside6,7,
Joyce Harper8,9, Sjoerd Repping10, Andreas Schmutzler11,
Katerina Vesela12, and Luca Gianaroli1
1Department of Reproductive Medicine, SISMER, Via Mazzini 12, Bologna 40138, Italy
2Department of Gynecological Endocrinology and
Reproductive Medicine, University of Bonn, Bonn, Germany
3Department of Genetics and Cell Biology, Research Institute GROW, Faculty of
Health, Medicine and Life Sciences, Maastricht University, PO Box 5800, Maastricht, 6202 AZ , The Netherlands
4Department of Obstetrics
and Gynecology, McMaster University, Hamilton, Canada
5ESHRE Central Ofﬁce, Grimbergen, Belgium
6London Bridge Fertility,
Gynaecology and Genetics Centre, London, UK
7BlueGnome Ltd, Cambridge, UK
8UCL Centre for PG&D, Institute for Women’s Health,
University College London, London, UK
9Centre for Reproductive and Genetic Health, UCLH, London, UK
10Center for Reproductive
Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
11Center for Reproductive Medicine, University Women’s Hospital, Christian-Albrechts-University Kiel, Kiel, Germany
12Sanatorium
Repromeda, Brno, Czech Republic
*Correspondence address. Tel: +39-051-307307; Fax: +39-051-302933; E-mail: cristina.magli@sismer.it
Submitted on July 29, 2011; resubmitted on July 29, 2011; accepted on August 9, 2011
background: The purpose of this study was to assess the technical aspects related to polar body (PB) biopsy, which might have an
inﬂuence on the results of the microarray comparative genomic hybridization analysis. Furthermore, a comparison was made between two
biopsy methods (mechanical and laser).
methods: Biopsy of the ﬁrst and second PB (PB1 and PB2) was performed by mechanical- or laser-assisted biopsy in two different IVF
centres. PBs were separately ampliﬁed by whole genome ampliﬁcation.
results: The method of biopsy, mechanical or laser had no inﬂuence on the proportion of successfully biopsied oocytes. Especially, for
the PB2, the timing of biopsy after ICSI was directly correlated to ampliﬁcation efﬁciency.
conclusions: Special care has to be taken with respect to the timing of biopsy of the PB2. Mechanical- and laser-assisted biopsy give
the same performance in terms of diagnostic efﬁciency.
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Introduction
Since its introduction in 1993 (Munne et al., 1993), preimplantation
genetic screening (PGS) of chromosome aneuploidy in human-assisted
reproduction has been performed predominantly by blastomere
biopsy at cleavage stages and interphase ﬂuorescent in situ hybridiz-
ation (FISH) for 5–8 chromosomes (Gianaroli et al., 1999; Munne
et al., 2003). Since it has been shown that the cleavage stage may
not be the best approach to identify aneuploidy reliably because of
the high incidence of chromosomal mosaicism, the European Society
of Human Reproduction and Embryology (ESHRE) Task Force on
PGS decided to initiate a pilot study of polar body (PB) biopsy and
chromosome copy number analysis using array comparative genomic
hybridization (CGH) to analyse the chromosome complement in
both the ﬁrst (PB1) and second (PB2) polar bodies. The clinical
results of this study are published separately (Geraedts et al., 2011).
Here, we critically examine how the quality of the results, and hence
the diagnosis, depends on aspects of the biopsy procedure.
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Patients
For this study only ICSI cycles with ejaculated spermatozoa were included.
There were no restrictions with respect to the maternal age of the
patients, their reproductive history or the number of retrieved or fertilized
oocytes.
Except for two cycles in the Bologna centre, in which the analysis was
performed on thawed oocytes, all cycles involved PB biopsy and analysis
in fresh cycles.
All patient materials were obtained and evaluated with informed patient
consent and under approval from the Ethics Committees from both
centres. The approval was given in Bologna by the Ethics Committee of
the SISMER center and in Bonn by the Local Ethics Committee
implemented for all medical research topics by the Medical Faculty at
the University of Bonn. Patients had to sign an informed consent prior
to entering the study.
Timing strategies
Hormone stimulation, follicular puncture and ICSI were performed
according to standard protocols. Contrary to the routine in the centre
in Bonn, ovulation induction was initiated at 1a.m. and consequently fol-
licular puncture as well as ICSI were postponed accordingly.
Individual time frames for each centre are shown in Table I.
For the two thawing cycles, cryopreservation had been performed by
slow-freezing (Magli et al., 2010) and the timing of thawing and PB
biopsy was scheduled to be equivalent to the biopsy in fresh cycles.
Special care was taken during denuding the oocyte with hyaluronidase
to remove all the cumulus cells adhering to the zona pellucida with the
aim of avoiding DNA contamination during the ampliﬁcation steps.
Simultaneous biopsy of both PB1 and PB2 was carried out at 6–9 h after
ICSI. At that time, PB2 is still tenuously connected by a cytoplasmic strand
to the oocyte and thus can be distinguished in the majority of the cases
from PB1 (Fig. 1). More important, spindle remnants are normally no
longer present within the connective cytoplasmic strand and therefore
there is no risk of accidentally removing chromatids from the oocyte. Gen-
erally, pronuclei are already visible at this time (Montag, 2010).
PB biopsy
The PB biopsy procedure was performed in dishes prepared with three
droplets of 3–5 ml buffered culture medium per oocyte overlaid with pre-
equilibrated mineral oil. One droplet was used for the oocyte and the
other two for sampling of PB1 and PB2 of the corresponding oocyte
after biopsy.
For removal of the PBs, the oocyte was ﬁrst rotated and held in a pos-
ition where both the PBs and the meridian of the oocyte were in the same
focal plane. In most cases, PB1 and PB2 could be distinguished based on
their morphology, as PB2 is normally slightly smaller and regular in
shape. In addition, within the time frame used in this study, at biopsy
PB2 was still linked to the oocyte with a cytoplasmic strand and hence
at a ﬁxed position within the perivitelline space, whereas PB1 could be dis-
located by gently pushing the oocyte with the biopsy capillary. Whenever
possible, PB2 was rotated to face towards the biopsy capillary to facilitate
breaking the connecting cytoplasmic strand. Where there was a signiﬁcant
distance between the position of PB1 and PB2, the oocyte was rotated so
that both PBs were in line with the biopsy capillary.
Mechanical biopsy
All PB biopsies in the Bologna centre were performed using mechanical
biopsy.
Mechanical biopsy was achieved using a micromanipulator with a double
holder that carried a partial zona dissection (PZD) glass microneedle and a
Figure 1 The presence of a faint but clearly identiﬁable strand con-
necting PB2 to the oolemma. The biopsy was performed  9 h after
ICSI.
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Table I Time frame for a cycle with PB biopsy and array CGH.
Bonn Bologna
Oocyte retrieval Day 0 Approx. 13:00 Day 0 Approx. 8:00
ICSI Day 0 20:30–21:00 Day 0 11:00–11:30
Biopsy/transfer to PCR tubes Day 1 5:20–5:40 Day 0 20:00–20:30
a
Ampliﬁcation Day 1 5:45–9:00 Day 0 20:40–23:45
Labelling/concentration Day 1 9:00–12:00 Day 0–Day 1 23:45–03:25
Hybridization Day 1 12:00–15:15 Day 1 3:25–6:30
Washing: Day 1 15:15–15:55 Day 1 6:30–7:05
Scanning/diagnosis
b Day 1 16:05–17:05 Day 1 7:05–8:05
Oocyte selection Day 1 17:05 Day 1 8:10
aThis is the time adopted for the last 65 consecutive biopsies in Bologna. For the previous oocytes, biopsy was performed 6–7 h after ICSI.
bTime frame for scan and diagnosis for six oocytes corresponding to 12 PBs. Additional six oocytes will require another 70 min.
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were carefully aligned in the same plane as the holding capillary.
To breach the zona pellucida, the oocyte was positioned with the two
PBs at the 2–3 o’clock position. The oocyte was then rotated in such a
way that the two PBs were vertically oriented along the meridian line
that ideally divides the zygote into two almost identical hemispheres at
both sides of the viewing ﬁeld.
A slit of  20 mm was made mechanically in the zona pellucida by
passing the PZD microneedle through the perivitelline space tangentially
to the oocyte, and the cut completed by temporarily releasing the
oocyte and repeatedly rubbing the PZD microneedle against the holding
capillary (Magli et al., 2006). When the slit was opened, the oocyte was
released from the holding capillary and rotated in such a way that the
slit was located at the 1 or 5 o’clock position with the two PBs in the
same plane on the left. The PBs were then gently aspirated with the
biopsy capillary as described later.
Laser-assisted PB biopsy
All biopsies in the Bonn centre were performed using laser-assisted biopsy.
For removal of PB1 and PB2, the oocyte was held in a position where
the PBs were located at the 1-o’clock position. Using a non-contact diode
laser (Octax, Bruckberg, Germany) an opening of 16–20 mm was drilled
with 2–4 laser shots. A ﬂame-polished blunt ended biopsy capillary (Tip
MML, Eppendorf, Hamburg, Germany) was then pushed smoothly
through the opening and towards PB2. Retrieval was accomplished by
sliding the capillary as far as possible over both PBs and they were both
aspirated with as little suction as necessary (Montag, 2009).
Once the capillary was removed, PB1 and PB2 were expelled in differ-
ent droplets of HEPES-buffered medium. For later transfer to the reaction
tubes, it was crucial to position each PB exactly in the middle of the cor-
responding droplet.
Transfer of PBs to the reaction tube
Transfer of PBs into the reaction tube was done in a laminar ﬂow cabinet
in order to avoid any contamination of the sample. Each reaction tube
was pre-ﬁlled with 1.6 ml phosphate-buffered saline (PBS) (BlueGnome,
Cambridge, UK). Under visual control in a stereomicroscope, a micropip-
ette (0.1–2.5 ml Research, Eppendorf) was inserted into the droplet
containing the PB and 0.4 ml of medium was drawn into the pipette.
Some of the medium was expelled over the PB in order to make sure
that it was not attached to the bottom of the dish. Next the PB was
sucked into the pipette in a total maximum volume of 0.4 ml. The tip
of the pipette was brieﬂy dipped into an uncovered drop of sterile PBS
to remove any oil derived from the biopsy dish. The pipette was then
lowered into the reaction tube until the tip was in contact with the
PBS of the tube and the PB was directly expelled into the PBS. The
reaction tube was closed immediately and stored on ice in a tube rack
until ampliﬁcation.
Successful PB transfer was checked by drawing the medium up and
down in the capillary tip under visual control.
Fragmented PBs
As the PB1 and PB2 were biopsied simultaneously 6–9 h after ICSI, PB1s
were occasionally fragmented, whereas PB2s remained in a single cell con-
ﬁguration. Fragmented PB2s could be retrieved as an entity as the frag-
ments usually stick together. However, once the fragments were
released in another medium droplet, special care was to be taken
during transfer into the PCR tube, as this step bears a certain risk of dis-
locating the fragments. PB2 could still be distinguished from PB1 fragments
due to its typical morphology and the presence of a cytoplasmic bridge
linking PB2 to the oolemma.
Whole genome ampliﬁcation and array CGH
The ampliﬁcation, labelling, hybridization and analysis procedure have been
published in the parallel paper (Geraedts et al., 2011).
Results
The biopsy methods used, laser-assisted in Bonn and mechanical in
Bologna, did not affect the proportion of successfully biopsied
oocytes. The only difference was a slightly longer time associated
with the mechanical biopsy (Table I).
Time frame of a treatment cycle with PB
biopsy and 12 h chromosomal analysis
When analysed per centre, the total ampliﬁcation rates of all PBs were
97% in Bonn (245/252) and 92% in Bologna (183/200, P , 0.025)
(Table II). The ampliﬁcation results obtained for PB1 were identical
for both centres (95 versus 94%, respectively), while for PB2 there
was a signiﬁcant difference (99% in Bonn versus 89% in Bologna;
P , 0.005).
Following detailed examination of differences in the protocol steps
for PB2 analysis, the timing of biopsy was found to be different
between Bonn and Bologna, i.e. biopsy was carried out 2–3 h
earlier in Bologna when compared with Bonn. Based on these con-
siderations, that became apparent during an interim analysis, the
biopsy of the last 65 consecutive oocytes in Bologna was delayed by
2–3 h with respect to the original protocol and was performed
 9 h after ICSI following the time schedule of Bonn. The correspond-
ing proportion of ampliﬁed PB2 in this series was 95% (62/65), which
was similar to that obtained in the other centre, while it was 77% (27/
35) in the ﬁrst series (P , 0.025).
In Bonn, no changes were made in the biopsy timing and the ampli-
ﬁcation rate remained constant during all the experiments.
Discussion
From the results of this study, it is possible to draw some relevant con-
clusions regarding the technical aspects involved in PB biopsies. It was
conﬁrmed that the technique is applicable in an IVF setting providing
the results in 12–13 h.
This timeframe overcomes one of the main drawbacks of CGH, i.e.
that until very recently, this technique was not compatible with a
fresh transfer especially when performing the biopsy at the blastocyst
stage. The protocol is quite ﬂexible, and longer incubation periods
can be adopted to make the procedure ﬁt into normal working
hours.Thetwobiopsymethodsusedinthisstudy,laserandmechanical,
didnotaffecttheproportionofsuccessfullybiopsiedoocytesconﬁrming
that the act of biopsy, when performed by a skilled practitioner, does
not apparently damage the oocyte. The only difference was the slightly
longer time needed for mechanical biopsy due to the fact that to open
the zona pellucida, the oocyte had to be detached from the holding
pipette and, when the slit was complete, it had to be relocated with
the opening at the 2 or 5 o’clock position to permit the entry of the
biopsy needle. It could be speculated that the mechanical procedure
is a compromise between a longer time of exposure to the external
environment and a more natural method compared with the use of
localized heat denaturation using a laser beam.
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revealed that the timing of PB biopsy plays a key role for the achieve-
ment of a diagnosis. For the purpose of the study, it was decided to
remove the two PBs simultaneously and the timing was decided in
the two centres according to their experience of PB analysis by
FISH. For practical reasons, Bonn decided to do the biopsy early in
the morning  9 h post injection, while in Bologna the procedure
was done late in the evening, initially at 6–7 h post injection. The
interval of 6 h after ICSI was considered to be necessary to allow com-
pletion of anaphase of the second meiotic division and to be sufﬁcient
to provide good quality results as conﬁrmed by FISH studies. Never-
theless, the process of whole genome ampliﬁcation revealed that there
is a signiﬁcant difference in the DNA status of PB2s biopsied at 6 h or
at 9 h post injection. As demonstrated by the rate of ampliﬁcation in
the two different conditions, DNA was more accessible to random
primers and Taq polymerase at 9 h post insemination when chromo-
somes had most likely completed telophase (Table II). Accordingly,
when the strategy in Bologna was adjusted to later biopsy timing,
the ampliﬁcation rate between the two centres was identical.
As for all cases involving DNA ampliﬁcation, especially from a single
cell, the presence of exogenous DNA has to be systematically avoided.
However, our results clearly show that if it is easy to control the biopsy
of PBs where every single step is done under visual control, oocyte col-
lection, especially in combination with the use of Pronase, is associated
with a higher risk of contamination by cumulus cell DNA, which might
be released during the enzymatic treatment.
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